{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:19:56Z","timestamp":1789712396790,"version":"4.0.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Dry eye disease (DED) is one of the most commonly diagnosed eye disorders, with a prevalence ranging from 5 to 50%, depending on the geographic location. DED is a multifactorial disorder of the tears and ocular surface, which results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is also accompanied by increased osmolarity of the tear film and inflammation of the surface of the eye. Multiple therapeutic agents have been used to treat DED, with glycerol emerging as a promising component of ophthalmic preparations, due to its humectant, lubricant, demulcent, and osmoprotective properties. This review aims to evaluate the current evidence concerning the therapeutic benefits of glycerol in managing DED, focusing on its possible mechanisms of action, clinical efficacy, and potential advantages over other treatments.<\/jats:p>","DOI":"10.3389\/fmed.2024.1531670","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:10:30Z","timestamp":1736917830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic benefits of glycerol in dry eye disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Victoria","family":"Ronderos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Bollag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"DES7","DOI":"10.1167\/iovs.17-23475","article-title":"Definition and diagnostic criteria of dry eye disease: historical overview and future directions","volume":"59","author":"Shimazaki","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0229421","DOI":"10.1371\/journal.pone.0229421","article-title":"NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models","volume":"15","author":"Matsuda","year":"2020","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/OPTO.S25571","article-title":"Evaluation of carboxymethylcellulose 0.5%\/glycerin 0.9% and sodium hyaluronate 0.18% artificial tears in patients with mild to moderate dry eye","volume":"3","author":"Roth","year":"2011","journal-title":"Clin Optomet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/jcm10061289","article-title":"Categorization of marketed artificial tear formulations based on their ingredients: a rational approach for their use","volume":"10","author":"Kathuria","year":"2021","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/jcm8081227","article-title":"Dry eye disease: a review of epidemiology in Taiwan, and its clinical treatment and merits","volume":"8","author":"Kuo","year":"2019","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","article-title":"The role and treatment of inflammation in dry eye disease","volume":"34","author":"Yagci","year":"2014","journal-title":"Int Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"109083","DOI":"10.1016\/j.exer.2022.109083","article-title":"Viscoelastic properties of the human tear film","volume":"219","author":"Recchioni","year":"2022","journal-title":"Exp Eye Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1167\/iovs.12-10819","article-title":"Ocular surface parameters in older male veterans","volume":"54","author":"Galor","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1167\/iovs.13-13330","article-title":"Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom","volume":"55","author":"Modi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ajo.2011.11.030","article-title":"Impact of ocular surface symptoms on quality of life in a United States veterans affairs population","volume":"153","author":"Pouyeh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"ref13","article-title":"Dry eye disease: a comprehensive review","volume-title":"Journal of International Conference Proceedings","author":"Dahal","year":"2020"},{"key":"ref14","volume-title":"Steroid-induced Glaucoma","author":"Feroze","year":"2024"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1307682","DOI":"10.3389\/fmed.2024.1307682","article-title":"Inflammation mechanism and anti-inflammatory therapy of dry eye","volume":"11","author":"Chu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref16","first-page":"40","article-title":"Distinguishing evaporative form aqueous deficient dry eye","author":"Lemp","year":"2011","journal-title":"Europe"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1177\/11206721221088259","article-title":"Dry eye disease, a prominent manifestation of systemic autoimmune disorders","volume":"32","author":"Bustamante-Arias","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref18","year":"2025"},{"key":"ref19","volume-title":"Dry eye syndrome","author":"Golden","year":"2024"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.18240\/ijo.2022.05.20","article-title":"Inflammation and dry eye disease-where are we?","volume":"15","author":"Rao","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"153712","DOI":"10.1016\/j.phymed.2021.153712","article-title":"Cascade of immune mechanism and consequences of inflammatory disorders","volume":"91","author":"Megha","year":"2021","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1039\/C3GC41857J","article-title":"Glycerol based solvents: synthesis, properties and applications","volume":"16","author":"Garcia","year":"2014","journal-title":"Green Chem"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1208\/s12249-021-01977-0","article-title":"Review of approaches for increasing ophthalmic bioavailability for eye drop formulations","volume":"22","author":"Lanier","year":"2021","journal-title":"AAPS Pharm Sci Tech"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/02713683.2022.2039205","article-title":"Management strategies for evaporative dry eye disease and future perspective","volume":"47","author":"Rolando","year":"2022","journal-title":"Curr Eye Res"},{"key":"ref25","article-title":"Master the maze of artificial tears","volume-title":"Rev Optometry","author":"Horton","year":"2018"},{"key":"ref26","author":"Larson","year":"2016"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/jop.2011.0053","article-title":"Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops","volume":"28","author":"Gensheimer","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ICO.0000000000002148","article-title":"Efficacy of the fluorescein tear breakup time test in dry eye","volume":"39","author":"Paugh","year":"2020","journal-title":"Cornea"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.colsurfb.2018.09.063","article-title":"Potentiality of microemulsion systems in treatment of ophthalmic disorders: keratoconus and dry eye syndrome - in vivo study","volume":"173","author":"Lidich","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0132656","DOI":"10.1371\/journal.pone.0132656","article-title":"Isotonic glycerol and sodium hyaluronate containing artificial tear decreases Conjunctivochalasis after one and three months: a self-controlled, unmasked study","volume":"10","author":"Kiss","year":"2015","journal-title":"PLoS One"},{"key":"ref31","volume-title":"Conjunctivochalasis","author":"Yvon","year":"2024"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.36848\/IJBAMR\/2020\/12210.51270","article-title":"Evaluating the role of glycerin as an adjuvant in tear substitute eye drops in patients with dry eye","volume":"9","author":"Gupta","year":"2020","journal-title":"Indian J Basic App Med Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clae.2018.12.003","article-title":"Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: a multicenter, double-masked, randomized 30-day study","volume":"42","author":"Lievens","year":"2019","journal-title":"Cont Lens Anterior Eye"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"18316","DOI":"10.18535\/jmscr\/v5i3.09","article-title":"A comparative study to evaluate the efficacy of carboxy methyl cellulose with glycerin and balanced electrolytes as excipients vs plain carboxy methyl cellulose, for keeping the eye moist","volume":"5","author":"Kiran","year":"2017","journal-title":"J Med Sci Clin Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"key":"ref36","first-page":"240","article-title":"Dry eye: an inflammatory ocular disease","volume":"9","author":"Hessen","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1038\/ncomms8454","article-title":"Aquaporin-3-mediated hydrogen peroxide transport is required for NF-kappaB signalling in keratinocytes and development of psoriasis","volume":"6","author":"Hara-Chikuma","year":"2015","journal-title":"Nat Commun"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"15681","DOI":"10.1073\/pnas.1005776107","article-title":"Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling","volume":"107","author":"Miller","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.3390\/ijms22168749","article-title":"Glycerol improves skin lesion development in the Imiquimod mouse model of psoriasis: experimental confirmation of anecdotal reports from patients with psoriasis","volume":"22","author":"Choudhary","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1523-1747.2003.12614.x","article-title":"Aquaporin 3 colocates with phospholipase D2 in caveolin-rich membrane microdomains and is regulated by keratinocyte differentiation","volume":"121","author":"Zheng","year":"2003","journal-title":"J Invest Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbamcr.2003.08.006","article-title":"Modulation of phospholipase D-mediated phosphatidylglycerol formation by differentiating agents in primary mouse epidermal keratinocytes","volume":"1643","author":"Zheng","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/sj.jid.5700921","article-title":"A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid","volume":"127","author":"Bollag","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/mol.119.118166","article-title":"Pathogen-associated molecular pattern-induced TLR2 and TLR4 activation increases keratinocyte production of inflammatory mediators and is inhibited by Phosphatidylglycerol","volume":"97","author":"Choudhary","year":"2020","journal-title":"Mol Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.3390\/ijms24065839","article-title":"Dioleoylphosphatidylglycerol inhibits heat shock protein B4 (HSPB4)-induced inflammatory pathways in vitro","volume":"24","author":"Fowler","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jid.2018.10.021","article-title":"Phosphatidylglycerol inhibits toll-like receptor-mediated inflammation by danger-associated molecular patterns","volume":"139","author":"Choudhary","year":"2019","journal-title":"J Invest Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/j.1440-1843.2006.00797.x","article-title":"Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity","volume":"11","author":"Chiba","year":"2006","journal-title":"Respirology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1194\/jlr.M065201","article-title":"Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling","volume":"57","author":"Kandasamy","year":"2016","journal-title":"J Lipid Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1074\/jbc.M110.170241","article-title":"Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages","volume":"286","author":"Kandasamy","year":"2011","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"25488","DOI":"10.1074\/jbc.M109.040832","article-title":"Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2","volume":"284","author":"Kuronuma","year":"2009","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1073\/pnas.0909361107","article-title":"Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection","volume":"107","author":"Numata","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1165\/rcmb.2011-0194OC","article-title":"Phosphatidylglycerol suppresses influenza a virus infection","volume":"46","author":"Numata","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1074\/jbc.RA119.012053","article-title":"Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models","volume":"295","author":"Numata","year":"2020","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1194\/jlr.M037077","article-title":"Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection","volume":"54","author":"Numata","year":"2013","journal-title":"J Lipid Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201006159","article-title":"Making heads or tails of phospholipids in mitochondria","volume":"192","author":"Osman","year":"2011","journal-title":"J Cell Biol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1074\/jbc.AW118.003229","article-title":"Phospholipid regulation of innate immunity and respiratory viral infection","volume":"294","author":"Voelker","year":"2019","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"102096","DOI":"10.1016\/j.nano.2019.102096","article-title":"Phosphatidylserine (PS) and phosphatidylglycerol (PG) nanodispersions as potential anti-inflammatory therapeutics: comparison of in vitro activity and impact of pegylation","volume":"23","author":"Klein","year":"2020","journal-title":"Nanomedicine"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.117.244756","article-title":"Soy Phosphatidylglycerol reduces inflammation in a contact irritant ear edema mouse model in vivo","volume":"366","author":"Xie","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.61.3.29","article-title":"Dioleoylphosphatidylglycerol accelerates corneal epithelial wound healing","volume":"61","author":"Bollag","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2337\/db13-1260","article-title":"Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFbeta3 expression contributes to the delay of epithelial wound healing in diabetic corneas","volume":"63","author":"Bettahi","year":"2014","journal-title":"Diabetes"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/emmm.201200221","article-title":"Identification of the HSPB4\/TLR2\/NF-kappaB axis in macrophage as a therapeutic target for sterile inflammation of the cornea","volume":"4","author":"Oh","year":"2012","journal-title":"EMBO Mol Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"849990","DOI":"10.3389\/fmed.2022.849990","article-title":"IL-17 producing lymphocytes cause dry eye and corneal disease with aging in RXRalpha mutant mouse","volume":"9","author":"Alam","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref62","year":""},{"key":"ref63","year":""},{"key":"ref64","first-page":"3156A","article-title":"Effect of a lipid emulsion drop on tear film characteristics of habitual contact lens wearers","volume":"56","author":"Rohit","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1531670\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:10:36Z","timestamp":1736917836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1531670\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":64,"alternative-id":["10.3389\/fmed.2024.1531670"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1531670","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1531670"}}